An in silico-in vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Mishto, M.; Mansurkhodzhaev, A.; Ying, G.; Bitra, A.; Cordfunke, R.A.; Henze, S.; ... ; Liepe, J. (2019)

Article / Letter to editor

• proteasome
• peptide splicing
• adoptive T cell therapy targets
• antigen presentation
• cancer epitopes
• KRAS
• tumor immunology

• All authors: Mishto, M.; Mansurkhodzhaev, A.; Ying, G.; Bitra, A.; Cordfunke, R.A.; Henze, S.; Paul, D.; Sidney, J.; Urlaub, H.; Neefjes, J.; Sette, A.; Zajonc, D.M.; Liepe, J.
• Date: 2019-11-15
• Journal: Frontiers in Immunology
• Volume: 10
• DOI: doi:10.3389/fimmu.2019.02572